Anti-outer dynein arm docking complex subunit 2 Antibody Products

Anti-outer dynein arm docking complex subunit 2 antibodies are used for the immunodetection of the protein encoded by the ODAD2 gene. In humans, the canonical protein has a reported length of 1044 amino acid residues and a mass of 115.7 kDa. Its subcellular localization is in the cytoplasm. Alternative splicing is reported to yield 2 different isoforms for this protein. It is reported to be expressed in respiratory epithelial cells. It is a known component of the outer dynein arm-docking complex (ODA-DC) that mediates outer dynein arms (ODA) binding onto the doublet microtubule. The gene encoding this protein is implicated in Ciliary dyskinesia. Other names for this target antigen include CILD23, gudu, armadillo repeat containing 4, armadillo repeat-containing protein 4, testis tissue sperm-binding protein Li 74n, and ARMC4. Gene orthologs have been identified in the mouse, rat, bovine, frog, zebrafish, chimpanzee and chicken species.

Anti-outer dynein arm docking complex subunit 2 Antibody Products

Your search terms and filters produced no results.

Please use the Antibodies search tool above to find what you're looking for.

Suggested Products

  • S-RMab® Tau (pT217) IVD Antibody Pair – Precision Markers for Alzheimer’s Detection

    The S-RMab® Tau (pT217) IVD antibody pair (Capture S0B3533; Detector S0B3059) provides a powerful solution for Alzheimer’s disease research and clinical diagnostics. Developed using AntBio’s proprietary Single B-Cell and recombinant technologies, these antibodies demonstrate superior affinity, minimal batch variability, and outstanding stability for precise detection of Tau phosphorylated at threonine-217—a key neurodegenerative biomarker. Ideal for ELISA, CLIA, and other immunodiagnostic ...
  • KRAS Related Products

    KRAS is one of the most frequently mutated oncogenes in human cancers, playing a critical role in tumor initiation, progression, and therapeutic resistance. Mutations such as KRAS G12C, G12D, G12V, and G13D are commonly observed in lung, colorectal, and pancreatic cancers, making KRAS a high-value but historically challenging drug target. TargetMol provides KRAS-related products, including a comprehensive range of small-molecule inhibitors, biochemical tools, and research reagents designed to ...
  • <<
  • >>

Recent Product Review

Guided Browse

Browse Antibodies by Antigen

Browse Antibodies by Clone